NF-κB-mediated degradation of the coactivator RIP140 regulates inflammatory responses and contributes to endotoxin tolerance

Nature Immunology

Volumn 13, Issue 4, 2012, Pages 379-386

  Ho, Ping Chih ^a   Tsui, Yao Chen ^a   Feng, Xudong ^a   Greaves, David R ^b   Wei, Li Na ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NUCLEAR RECEPTOR COACTIVATOR; RECEPTOR INTERACTING PROTEIN 140; TRANSCRIPTION FACTOR RELA; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE TARGETING; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SUBUNIT; REGULATORY MECHANISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CHROMATIN IMMUNOPRECIPITATION; ENDOTOXINS; GENE KNOCKDOWN TECHNIQUES; IMMUNE TOLERANCE; IMMUNOBLOTTING; INFLAMMATION; MICE; MICE, TRANSGENIC; NF-KAPPA B; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN-PROTEIN LIGASES;

EID: 84858703294     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2238     Document Type: Article

References (49)

1. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
2. O'Neill, L.A. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 29, 12-20 (2008).
3. Baker, R.G., Hayden, M.S. & Ghosh, S. NF-κB, inflammation, and metabolic disease. Cell Metab. 13, 11-22 (2011).
4. Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408-415 (2011).
5. Tabas, I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10, 36-46 (2010).
6. Sheedy, F.J. et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11, 141-147 (2010).
7. Mansell, A. et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7, 148-155 (2006).
8. Foster, S.L., Hargreaves, D.C. & Medzhitov, R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972-978 (2007).
9. Chen, J. & Ivashkiv, L.B. IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling. Proc. Natl. Acad. Sci. USA 107, 19438-19443 (2010).
10. Nathan, C. & Ding, A. Nonresolving inflammation. Cell 140, 871-882 (2010).
11. Biswas, S.K. & Lopez-Collazo, E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475-487 (2009).
12. Park, S.H., Park-Min, K.H., Chen, J., Hu, X. & Ivashkiv, L.B. Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nat. Immunol. 12, 607-615 (2011).
13. Chan, C., Li, L., McCall, C.E. & Yoza, B.K. Endotoxin tolerance disrupts chromatin remodeling and NF-κB transactivation at the IL-1β promoter. J. Immunol. 175, 461-468 (2005).
14. White, R. et al. Role of RIP140 in metabolic tissues: connections to disease. FEBS Lett. 582, 39-45 (2008).
15. Fritah, A., Christian, M. & Parker, M.G. The metabolic coregulator RIP140: an update. Am. J. Physiol. Endocrinol. Metab. 299, E335-E340 (2010).
16. Lee, C.H., Chinpaisal, C. & Wei, L.N. Cloning and characterization of mouse RIP140, a corepressor for nuclear orphan receptor TR2. Mol. Cell. Biol. 18, 6745-6755 (1998).
17. Leonardsson, G. et al. Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc. Natl. Acad. Sci. USA 101, 8437-8442 (2004).
18. Christian, M. et al. RIP140-targeted repression of gene expression in adipocytes. Mol. Cell. Biol. 25, 9383-9391 (2005).
19. Ho, P.C., Lin, Y.W., Tsui, Y.C., Gupta, P. & Wei, L.N. A negative regulatory pathway of GLUT4 trafficking in adipocyte: new function of RIP140 in the cytoplasm via AS160. Cell Metab. 10, 516-523 (2009).
20. Ho, P.C., Chuang, Y.S., Hung, C.H. & Wei, L.N. Cytoplasmic receptor-interacting protein 140 (RIP140) interacts with perilipin to regulate lipolysis. Cell. Signal. 23, 1396-1403 (2011).
21. Ho, P.C. & Wei, L.N. Negative regulation of adiponectin secretion by receptor interacting protein 140 (RIP140). Cell Signal. 24, 71-76 (2012).
22. Mostaqul Huq, M.D., Gupta, P. & Wei, L.N. Post-translational modifications of nuclear co-repressor RIP140: a therapeutic target for metabolic diseases. Curr. Med. Chem. 15, 386-392 (2008).
23. Huq, M.D., Ha, S.G., Barcelona, H. & Wei, L.N. Lysine methylation of nuclear co-repressor receptor interacting protein 140. J. Proteome Res. 8, 1156-1167 (2009).
24. Gupta, P. et al. PKCε stimulated arginine methylation of RIP140 for its nuclear-cytoplasmic export in adipocyte differentiation. PLoS ONE 3, e2658 (2008).
25. Ho, P.C. et al. Modulation of lysine acetylation-stimulated repressive activity by Erk2-mediated phosphorylation of RIP140 in adipocyte differentiation. Cell. Signal. 20, 1911-1919 (2008).
26. Zschiedrich, I. et al. Coactivator function of RIP140 for NFκB/RelA-dependent cytokine gene expression. Blood 112, 264-276 (2008).
27. Ho, P.C., Chang, K.C., Chuang, Y.S. & Wei, L.N. Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J. 25, 1758-1766 (2011).
28. Clague, M.J. & Urbe, S. Ubiquitin: same molecule, different degradation pathways. Cell 143, 682-685 (2010).
29. Natoli, G. & Chiocca, S. Nuclear ubiquitin ligases, NF-κB degradation, and the control of inflammation. Sci. Signal. 1, pe1 (2008).
30. Maine, G.N., Mao, X., Komarck, C.M. & Burstein, E. COMMD1 promotes the ubiquitination of NF-κB subunits through a cullin-containing ubiquitin ligase. EMBO J. 26, 436-447 (2007).
31. Freudenberg, M.A. & Galanos, C. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect. Immun. 56, 1352-1357 (1988).
32. Vats, D. et al. Oxidative metabolism and PGC-1κ attenuate macrophage-mediated inflammation. Cell Metab. 4, 13-24 (2006).
33. Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35 (2003).
34. Mosser, D.M. & Edwards, J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969 (2008).
35. Kinjyo, I. et al. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17, 583-591 (2002).
36. Nakagawa, R. et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 17, 677-687 (2002).
37. Dimitriou, I.D. et al. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol. Rev. 224, 265-283 (2008).
38. Hamerman, J.A., Tchao, N.K., Lowell, C.A. & Lanier, L.L. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat. Immunol. 6, 579-586 (2005).
39. Han, C. et al. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat. Immunol. 11, 734-742 (2010).
40. Hu, X., Chakravarty, S.D. & Ivashkiv, L.B. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 226, 41-56 (2008).
41. Medzhitov, R. & Horng, T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9, 692-703 (2009).
42. Smale, S.T. Selective transcription in response to an inflammatory stimulus. Cell 140, 833-844 (2010).
43. Strebovsky, J., Walker, P., Lang, R. & Dalpke, A.H. Suppressor of cytokine signaling 1 (SOCS1) limits NFκB signaling by decreasing p65 stability within the cell nucleus. FASEB J. 25, 863-874 (2011).
44. Yoon, C.H., Miah, M.A., Kim, K.P. & Bae, Y.S. New Cdc2 Tyr 4 phosphorylation by dsRNA-activated protein kinase triggers Cdc2 polyubiquitination and G2 arrest under genotoxic stresses. EMBO Rep. 11, 393-399 (2010).
45. Yoo, Y., Ho, H.J., Wang, C. & Guan, J.L. Tyrosine phosphorylation of cofilin at Y68 by v-Src leads to its degradation through ubiquitin-proteasome pathway. Oncogene 29, 263-272 (2010).
46. Oeckinghaus, A., Hayden, M.S. & Ghosh, S. Crosstalk in NF-κB signaling pathways. Nat. Immunol. 12, 695-708 (2011).
47. Wei, L.N., Hu, X., Chandra, D., Seto, E. & Farooqui, M. Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J. Biol. Chem. 275, 40782-40787 (2000).
48. Vo, N., Fjeld, C. & Goodman, R.H. Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP. Mol. Cell. Biol. 21, 6181-6188 (2001).
49. Rao, M.K. & Wilkinson, M.F. Tissue-specific and cell type-specific RNA interference in vivo. Nat. Protoc. 1, 1494-1501 (2006).